Bristol Myers Squibb Receives European Commission Approval for LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab), for the Treatment of Unresectable or Metastatic Melanoma with Tumor Cell PD-L1 Expression < 1% Read more
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A’s Cardio-Metabolic Therapies Read more
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics Read more
WHO Expands Recommendation for Veklury (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline Read more
Meet Pfizer, AstraZeneca, DiME & many more at the Biosensors for Medical Wearables Conference Read more
Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto Read more
Mallinckrodt Receives FDA Approval for Terlivaz (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) Read more
BriaCell Partners with Caris Life Sciences to Expand Patient Outreach and Molecular Profiling Read more